ArticleBMC medical imaging2025
Predicting outcomes in head and neck cancer using CT images via transfer learning.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccurate preoperative risk stratification for patients with head and neck (H&N) cancer remained a critical challenge, as long-term survival rates are poor despite aggressive multimodality treatment. While deep learning models showed promise for outcome prediction from medical images, their typical requirement for massive datasets presented a significant barrier to development and clinical translation. To overcome this limitation, we developed a transfer learning-based framework to accurately predict key treatment outcomes, locoregional recurrence (LR), distant metastasis (DM), and overall survival (OS), from non-invasive computed tomography (CT) images.
methodsOur framework, OPHN-Net, utilized a VGG16 architecture pre-trained on ImageNet. The framework was trained and validated using a public dataset from The Cancer Imaging Archive, which comprises CT images and clinical data for 296 patients from four independent institutions. To overcome data limitations and class imbalance, we implemented a novel random-plane view resampling method for data augmentation. The network was trained and validated on data from two institutions and then independently tested on a cohort from the remaining two. Finally, we constructed an integrated model by combining the predictions from our imaging-based model with key clinical characteristics to further enhance performance.
resultsOn the independent test cohort, our OPHN-Net framework substantially outperformed both traditional radiomics and a previously published deep learning model across all endpoints. The model achieved AUCs of 0.84 (95% CI, 0.75-0.90) for LR, 0.89 (95% CI, 0.82-0.95) for DM, and 0.79 (95% CI, 0.70-0.87) for OS. Furthermore, integrating clinical characteristics with the imaging-based predictions yielded a final model with even greater performance, boosting the AUCs to 0.87 (95% CI, 0.80-0.93) for LR, 0.91 (95% CI, 0.83-0.95) for DM, and 0.86 (95% CI, 0.78-0.92) for OS.
conclusionOur transfer learning-based framework, OPHN-Net, provided a robust and data-efficient method for predicting treatment outcomes in H&N cancer from non-invasive CT images. The integration of imaging-based predictions with clinical characteristics created a more comprehensive prognostic model. This approach had the potential to facilitate personalized treatment stratification, ultimately leading to improved clinical decision-making and patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.